We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
sterile single-dose-units for parapharmaceutical applications

Neuraxpharm covers a to z drugs

Neuraxpharm also owns and operates two manufacturing plants in Spain
  • B2B solutions provider dedicated to the development and manufacturing of finished dosage forms (FDFs)
  • Focused on the development and manufacturing of the highest quality active pharmaceutical ingredients (APIs) with complex synthesis processes

[*] Differentiated product
[**] Opioid

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.

© Neuraxpharm / LESVI. All rights reserved.